Mukunthan KS

Mukunthan KS


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2024 in Molecular Biotechnology
Verified
Journal Article
Open access
PDF file
AMArnab Mukherjee
Arnab Mukherjee
SASuzanna Abraham
Suzanna Abraham
ASAkshita Singh
Akshita Singh
Seetharaman BalajiSeetharaman Balaji
Seetharaman Balaji
AMArnab Mukherjee
Arnab Mukherjee
In the dynamic landscape of targeted therapeutics, drug discovery has pivoted towards understanding underlying disease mechanisms, placing a strong emphasis on molecular perturbations and target identification. This paradigm shift, crucial for drug discovery, is underpinned by big data, a transformative force in the current era. Omics data, characterized by its heterogeneity and enormity, has ushered biological and biomedical research into the big data domain. Acknowledging the significance of integrating diverse omics data strata, known as multi-omics studies, researchers delve into the intricate interrelationships among various omics layers. This review navigates the expansive omics landscape, showcasing tailored assays for each molecular layer through genomes to metabolomes. The sheer volume of data generated necessitates sophisticated informatics techniques, with machine-learning (ML) algorithms emerging as robust tools. These datasets not only refine disease classification but also enhance diagnostics and foster the development of targeted therapeutic strategies. Through the integration of high-throughput data, the review focuses on targeting and modeling multiple disease-regulated networks, validating interactions with multiple targets, and enhancing therapeutic potential using network pharmacology approaches. Ultimately, this exploration aims to illuminate the transformative impact of multi-omics in the big data era, shaping the future of biological research.

28 October 2025 in BMC Pharmacology and Toxicology
Verified
Journal Article
Open access
PDF file
UDUddalak Das
Uddalak Das
AMArnab Mukherjee
Arnab Mukherjee
MKMukunthan KS
Mukunthan KS
JKJitendra Kumar
Jitendra Kumar
Leukemia, a hematologic malignancy, frequently involves the overexpression of BCL-2 proteins, contributing to cell survival and apoptosis resistance. Although current BCL-2 inhibitors, including Venetoclax, have shown efficacy, they are limited by adverse side effects and restricted bioavailability. This study employs an integrated computational approach to identify natural BCL-2 inhibitors by screening 407,270 natural compounds. Using ligand- and structure-based virtual screening, we identified two promising compounds, CNP0237679 and CNP0420384, demonstrating strong binding affinities, favorable electronic properties, and stability in dynamic aqueous environments. Both compounds exhibited promising toxicity and pharmacokinetic profiles, indicating the possibility of low toxicity and high bioavailability. They are potential candidates for developing selective BCL-2 inhibitors because of these characteristics. The findings represent a positive step in developing new, naturally derived BCL-2 inhibitors and support additional in vitro and in vivo studies to validate their therapeutic efficacy and safety characteristics.

28 September 2023 in Molecular Biotechnology
Verified
Journal Article
Open access
PDF file
AMArnab Mukherjee
Arnab Mukherjee
PYPreeti Harigovind Yadav
Preeti Harigovind Yadav
MKMukunthan KS
Mukunthan KS
Lung adenocarcinoma (LUAD) is one of the most prevalent and leading causes of cancer deaths globally, with limited diagnostic and clinically significant therapeutic targets. Identifying the genes and processes involved in developing and progressing LUAD is crucial for developing effective targeted therapeutics and improving patient outcomes. Therefore, the study aimed to explore the RNA sequencing data of LUAD from The Cancer Genome Atlas (TCGA) and gene expression profile datasets involving GSE10072, GSE31210, and GSE32863 from the Gene Expression Omnibus (GEO) databases. The differential gene expression and the downstream analysis determined clinically significant biomarkers using a network-based approach. These therapeutic targets predominantly enriched the dysregulation of mitotic cell cycle regulation and revealed the co-overexpression of Aurora-A Kinase (AURKA) and Targeting Protein for Xklp2 (TPX2) with high survival risk in LUAD patients. The hydrophobic residues of the AURKA–TPX2 interaction were considered as the target site to block the autophosphorylation of AURKA during the mitotic cell cycle. The tyrosine kinase inhibitor (TKI) dacomitinib demonstrated the strong binding potential to hinder TPX2, shielding the AURKA destabilization. This in silico study lays the foundation for repurposing targeted therapeutic options to impede the Protein–Protein Interactions (PPIs) in LUAD progression and aid in future translational investigations.

12 July 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AMArnab Mukherjee
Arnab Mukherjee
SVSai Eashan Vankamamidi
Sai Eashan Vankamamidi
MKMukunthan KS
Mukunthan KS
Cadmium chloride (CdCl₂), a highly toxic environmental pollutant, significantly impacts kidney health, particularly in the proximal tubular cells, where it induces oxidative stress and lipid peroxidation. The specific mechanisms underlying cadmium toxicity remain unclear. It is hypothesized that it is mediated by microRNAs (miRNAs). These non-coding RNAs regulate gene expression by promoting mRNA degradation and translational repression. In this study, microarray data from HK-2 cells exposed to CdCl₂ was analyzed, revealing increased oxidative stress and disrupted mitochondrial function. The prolonged cadmium exposure disrupted gene expression and induced persistent toxicity. Notably, six miRNAs predominantly modulated the hub genes. A molecular interaction study of miRNA-mRNA duplexes indicated a strong interaction with the argonaute (AGO) protein of the RNA-induced silencing complex (RISC), suggesting that miRNA-mediated gene silencing plays a crucial role in cadmium-induced renal damage. These findings highlight the critical role of miRNAs in modulating cadmium toxicity and suggest their potential as biomarkers for cadmium-induced renal dysfunction.

17 March 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AMArnab Mukherjee
Arnab Mukherjee
MBManon Boonbangyang
Manon Boonbangyang
MKMukunthan KS
Mukunthan KS
Lung adenocarcinoma (LUAD) remains a leading cause of cancer-related mortalities, characterized by substantial genetic heterogeneity that challenges a comprehensive understanding of its progression. This study employs next-generation sequencing data analysis to transform our comprehension of LUAD pathogenesis. Integrating epigenetic and transcriptomic data of LUAD patients, this approach assessed the critical regulatory occurrences, identified therapeutic targets, and offered profound insights into cancer molecular foundations. We employed the DNA methylation data to identify differentially methylated CpG sites and explored the transcriptome profiles of their adjacent genes. An intersectional analysis of gene expression profiles uncovered 419 differentially expressed genes (DEGs) influenced by smoke-induced differential DNA methylation, among which hub genes, including mitochondrial ribosomal proteins (MRPs), and ribosomal proteins (RPs) such as MRPS15, MRPS5, MRPL33, RPL24, RPL7L1, MRPL15, TUFM, MRPL22, and RSL1D1, were identified using a network-based approach. These hub genes were overexpressed and enriched to RNA processing, ribosome biogenesis, and mitochondrial translation, which is critical in LUAD progression. Enhancer Linking Methylation/Expression Relationship (ELMER) analysis revealed transcription factor (TF) binding motifs, such as JUN, NKX23, FOSB, RUNX3, and FOSL1, which regulated these hub genes through methylation-dependent enhancer dynamics. Predominant hypomethylation of MRPs and RPs disrupted mitochondrial function, contributed to oxidative phosphorylation (OXPHOS) and metabolic reprogramming, favoring cancer cell survival. The survival analysis validated the clinical relevance of these hub genes, with high-expression cohorts exhibiting poor overall survival (OS) outcomes enlightened their relevance in LUAD pathogenesis and presented the potential for developing novel targeted therapeutic strategies.

6 February 2026 in Discover Materials
Verified
Journal Article
Open access
PDF file
YPYimtar L. Pongen
Yimtar L. Pongen
SBSaivenkatesh Kiran Bollapragreate
Saivenkatesh Kiran Bollapragreate
BCBalachandar Chinnappa
Balachandar Chinnappa
TSThanigaivel Sundaram
Thanigaivel Sundaram
LGLalitha Gnanasekaran
Lalitha Gnanasekaran
DTDurairaj Thirumurugan
Durairaj Thirumurugan
Traditional concrete made with the use of Portland cement is the industry standard and widely used in construction. However, it faces significant challenges in terms of long-term durability and reliability, particularly when exposed to harsh environmental conditions over prolonged periods. The major concern is the development of microcracks, which can compromise the structural integrity of the material. To combat these issues, extensive research is ongoing in the development of self-healing concrete through the use of biomineralizing bacteria that can detect and heal the cracks automatically, eliminating the need for analytical monitoring or human intervention. Additionally, researchers are exploring the use of different materials, ranging from polymers to synthetic materials, including nanoparticles, to enhance the functionality of concrete, apart from its load-bearing ability, which essentially develops a form of multifunctional concrete. In this review, we aim to discuss the different technologies that are being studied for the development of sustainable multifunctional concrete; the different materials used, the protocols involved and their overall mechanistic properties to facilitate a comparison and summarize the future research. We also aim to segregate and discuss which approach results in better outcomes, considering the economic factors, including scalability and ease of use in terms of application in the real world.